The DOI matches its Crossref record; 45 of the 49 references it cites were found in a registry or an index.
A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration
Open accessAbstract
The neuronal ceroid lipofuscinoses (NCLs) constitute a group of neurodegenerative storage diseases characterized by progressive psychomotor retardation, blindness and premature death. Pathologically, there is accumulation of autofluorescent material in lysosome-derived organelles in a variety of cell types, but neurons in the central nervous system appear to be selectively affected and undergo progressive death. In this report we show that a novel form of NCL, congenital ovine NCL, is caused by a deficiency in the lysosomal aspartyl proteinase cathepsin D. A single nucleotide mutation in the cathepsin D gene results in conversion of an active site aspartate to asparagine, leading to production of an enzymatically inactive but stable protein. This results in severe cerebrocortical atrophy and early death, providing strong evidence for an important role of cathepsin D in neuronal development and/or homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CTSD is a ubiquitous protease, but its unique importance in brain is illustrated by the relatively selective neurodevelopmental and progressive neurodegenerative phenotype induced by the loss-of-function CTSD mutations causing the congenital disorder neuronal ceroid lipofuscinosis CLN10 (Tyynela ¨et al., 2000;Siintola et al., 2006).”
From Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99) (2019) · cites this paper as Tyynela ¨et al., 2000
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Handbook of Proteolytic Enzymes
(2004) · Elsevier eBooks · doi:10.1016/c2009-0-03628-9 · Cited by 2,623
[41] Cathepsin B, cathepsin H, and cathepsin L
Barrett, A. J., & Kirschke, H. (1981) · Methods in Enzymology · doi:10.1016/s0076-6879(81)80043-2 · Cited by 1,698
The Handbook of proteolytic enzymes
Barrett, A. J., Rawlings, N. D., & Woessner, J. F. (1998) · Cited by 1,119
Vesa, J., Hellsten, E., Verkruyse, L. A., Camp, L. A., Rapola, J., Santavuori, P., Hofmann, S. L., & Peltonen, L. (1995) · Nature · doi:10.1038/376584a0 · Cited by 736
The Structure and Function of the Aspartic Proteinases
Davies, D. R. (1990) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.19.060190.001201 · Cited by 658
Isolation of a novel gene underlying batten disease, CLN3
Lerner, T. J., Boustany, R., Anderson, J. W., D'Arigo, K. L., Schlumpf, K. S., Buckler, A., Gusella, J. F., & Haines, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90274-0 · Cited by 598
Sleat, D. E., DONNELLY, R. J., Lackland, H., Liu, C., Sohár, I., Pullarkat, R. K., & Lobel, P. (1997) · Science · doi:10.1126/science.277.5333.1802 · Cited by 581
Self-citationSäftig, P., Hetman, M., Schmahl, W. W., Weber, K., Heine, L., Mossmann, H., Köster, A., Heß, B., Evers, M., & FIGURA, K. V. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00029.x · Cited by 439
The Presenilins in Alzheimer's Disease--Proteolysis Holds the Key
Haass, C., & Strooper, B. D. (1999) · Science · doi:10.1126/science.286.5441.916 · Cited by 388
Research works printed but not linked: 1
- Kohlshütter A and Lake BD (1999) NCL variants without genetic assignment. In Goebel,H.H., Mole,S.E. and Lake,B.D. (eds), Biomedical and Health Research, Vol. 33. IOS Press, Amsterdam, The Netherlands, pp. 125–127.
Cited by
Sorted by citations
Cathepsin D--many functions of one aspartic protease
Benes, P., Vetvicka, V., & Fusek, M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.02.008 · Cited by 572
Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis
Siintola, E. (2006) · Brain · doi:10.1093/brain/awl107 · Cited by 389
Loss of the chloride channel ClC‐7 leads to lysosomal storage disease and neurodegeneration
Kasper, D., Planells‐Cases, R., Fuhrmann, J. C., Scheel, O., Zeitz, O., Rüether, K., Schmitt, A. M., Poët, M., Steinfeld, R., Schweizer, M., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600576 · Cited by 377
Neurodegenerative lysosomal disorders: A continuum from development to late age
Nixon, R. A., Yang, D.-S., & Lee, J.-H. (2008) · Autophagy · doi:10.4161/auto.6259 · Cited by 362
The Neuronal Ceroid-Lipofuscinoses
Haltia, M. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.1 · Cited by 354
Self-citation
Metadata
- Authors
- Tyynelä, J., Sohar, I., Sleat, D. E., Gin, R. M., Donnelly, R. J., Baumann, M., Haltia, M., & Lobel, P.
- Affiliations
- University of Helsinki (FI)
- Rutgers, The State University of New Jersey (US)
- Rutgers New Jersey Medical School (US)
- Corresponding author
- Tyynelä, Jaana
- Lobel, Peter
- Venue
- The EMBO Journal
- Published
- 2000-06-15
- Volume
- 19
- Issue
- 12
- Pages
- 2786-2792
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC203370
- OpenAlex
- W2040107841
- Cited by
- 245
- References
- 49
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 4 · 2020: 7 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 10 · 2015: 7 · 2014: 5 · 2013: 12 · 2012: 14
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Lastentautien Tutkimussäätiö
- National Institutes of Health (5r01dk045992-08)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-54317, DK-45992, R01DK054317)
- National Institute of Neurological Disorders and Stroke (NS-37918, R01NS037918)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Nephrology › Biomedical Research and Pathophysiology
- Keywords
- neuronal ceroid lipofuscinosis, cathepsin D, lysosomal storage disease, neurodegeneration, sheep model, point mutations, lysosomal protein degradation, neuronal development
- MeSH terms
- Amino Acid Sequence, Animals, Cathepsin D, Liver, Lysosomes, Molecular Sequence Data, Mutation, Neuronal Ceroid-Lipofuscinoses, Sheep, Sequence Homology, Amino Acid, Lysosomal Storage Diseases, Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
